SS Innovations International, Inc. (NASDAQ: SSII) has been named Outstanding Company at the 2026 Surgical Robotics Industry Awards, surpassing a field of finalists that included industry giants Intuitive Surgical (NASDAQ: ISRG), Johnson & Johnson (NYSE: JNJ), and Medtronic (NYSE: MDT). The award recognizes a single company demonstrating excellence in innovation, commercial success, industry leadership and positive societal impact.
Other finalists for the top honor included MedTech, MicroPort Scientific (HKEX: 0853), Distalmotion, FUTEK, Meril, Precision IO Group, and THINK Surgical. The selection of SS Innovations highlights the company's growing prominence in the surgical robotics field, traditionally dominated by established players.
SS Innovations develops innovative surgical robotic technologies with a mission to make robotic surgery affordable and accessible to a larger segment of the global population. Its product range includes the proprietary “SSi Mantra” surgical robotic system and the comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of procedures including cardiac surgery.
The company, an American firm headquartered in India, plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. The award signals a shift in the competitive landscape, potentially opening up new market opportunities for SS Innovations as it challenges incumbents.
For investors, the recognition underscores the company's potential for growth. The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII.
